Different Cycles of Neoadjuvant PD-1 Blockades + Chemotherapy for Advanced Gastric Cancer

NCT06798376 · clinicaltrials.gov ↗

RECRUITING

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Gastric Adenocarcinoma

Interventions

DRUG: ≤4 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy
DRUG: ≥5 cycles of neoadjuvant PD-1 Inhibitors combined with chemotherapy
PROCEDURE: Gastrectomy

Sponsor

Chinese PLA General Hospital